Reference
Ruck T, et al. Vitiligo after alemtuzumab treatment: Secondary autoimmunity is not all about B cells. Neurology 91: E2233-E2237, No. 24, 11 Dec 2018. Available from: URL: http://doi.org/10.1212/WNL.0000000000006648 - Germany
Rights and permissions
About this article
Cite this article
Alemtuzumab. Reactions Weekly 1763, 29 (2019). https://doi.org/10.1007/s40278-019-65121-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-65121-x